Fibric Acid Derivatives

Alona Crowder, PharmD, Simeon Margolis, M.D.

INDICATIONS

FDA

  • Primary hypercholesterolemia or mixed dyslipidemia: To reduce LDL, total cholesterol, and triglycerides.
    • Of note, this class of medications has not shown a reduction in coronary heart disease morbidity and mortality in large, randomized controlled trials of patients with type 2 diabetes mellitus.[1][2]
  • Hypertriglyceridemia: Adjunct to diet treatment and improved glycemic control in patients with diabetes.

NON-FDA APPROVED USES

  • Prevention of acute pancreatitis secondary to severe hypertriglyceridemia

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: January 7, 2018